Jiangsu Nutai Biologics Co., Ltd

This early-phase trial tests a new drug called SXRN, made from DNA, in 28 people with advanced solid tumors who have run out of standard options. The main goals are to check safety and find the right dose, while also seeing if it helps with appetite and physical function. The stu…

This early-stage study tests a new injection called SXRN in 54 cancer patients who have lost their appetite and weight due to their illness. The main goal is to see if the drug is safe and to find the best dose. Researchers will also check if it helps improve appetite and weight …